Condition: HIV Prevention · Substance Use · Mental Health Disorders · Sponsor: Institute of HIV Research and Innovation Foundation, Thailand
This study evaluates a comprehensive transgender-tailored harm reduction service for transgender women, transgender men, and non-binary individuals engaging in chemsex or substance use in Thailand, focusing on PrEP uptake, HIV/STI outcomes, mental health, and socio-legal impacts.
This description comes directly from the study's public registry record.
Nittaya Phanuphak, MD,PhD. · 6681 825 3544 · nittaya.p@ihri.org
Rena Janamnuaysook, MBA · 6698 516 4562 · rena.j@ihri.org
Always discuss trial participation with your own doctor first.
| Tangerine Clinic, Institute of HIV Research and Innovation | Pathum Wan, Bangkok, Thailand | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07512856